Literature DB >> 33826816

Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351).

Thandeka Moyo-Gwete1, Mashudu Madzivhandila1, Zanele Makhado1, Frances Ayres1, Donald Mhlanga1, Brent Oosthuysen1, Bronwen E Lambson1, Prudence Kgagudi1, Houriiyah Tegally2, Arash Iranzadeh3, Deelan Doolabh3, Lynn Tyers3, Lionel R Chinhoyi3, Mathilda Mennen3, Sango Skelem3, Gert Marais3, Constantinos K Wibmer1, Jinal N Bhiman1, Veronica Ueckermann4, Theresa Rossouw5, Michael Boswell4, Tulio de Oliveira2, Carolyn Williamson3, Wendy A Burgers3, Ntobeko Ntusi3, Lynn Morris6, Penny L Moore6.   

Abstract

Entities:  

Year:  2021        PMID： 33826816     DOI： 10.1056/NEJMc2104192

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  47 in total

1.  Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants.

Authors:  Marianna Agudelo; Frauke Muecksch; Dennis Schaefer-Babajew; Alice Cho; Justin DaSilva; Eva Bednarski; Victor Ramos; Thiago Y Oliveira; Melissa Cipolla; Anna Gazumyan; Shuai Zong; Danielle A S Rodrigues; Guilherme S Lira; Luciana Conde; Renato Santana Aguiar; Orlando C Ferreira; Amilcar Tanuri; Katia C Affonso; Rafael M Galliez; Terezinha Marta Pereira Pinto Castineiras; Juliana Echevarria-Lima; Marcelo Torres Bozza; Andre M Vale; Paul D Bieniasz; Theodora Hatziioannou; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2022-07-07       Impact factor: 17.579

2.  Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques.

Authors:  Nerea Zabaleta; Urja Bhatt; Cécile Hérate; Pauline Maisonnasse; Julio Sanmiguel; Cheikh Diop; Sofia Castore; Reynette Estelien; Dan Li; Nathalie Dereuddre-Bosquet; Mariangela Cavarelli; Anne-Sophie Gallouët; Quentin Pascal; Thibaut Naninck; Nidhal Kahlaoui; Julien Lemaitre; Francis Relouzat; Giuseppe Ronzitti; Hendrik Jan Thibaut; Emanuele Montomoli; James M Wilson; Roger Le Grand; Luk H Vandenberghe
Journal:  Mol Ther       Date:  2022-05-10       Impact factor: 12.910

3.  A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant.

Authors:  Nitin Hingankar; Suprit Deshpande; Payel Das; Zaigham Abbas Rizvi; Constantinos Kurt Wibmer; Poppy Mashilo; Mohammed Yousuf Ansari; Alison Burns; Shawn Barman; Fangzhu Zhao; Sohini Mukherjee; Jonathan L Torres; Souvick Chattopadhyay; Farha Mehdi; Jyoti Sutar; Deepak Kumar Rathore; Kamal Pargai; Janmejay Singh; Sudipta Sonar; Kamini Jakhar; Jyotsna Dandotiya; Sankar Bhattacharyya; Shailendra Mani; Sweety Samal; Savita Singh; Pallavi Kshetrapal; Ramachandran Thiruvengadam; Gaurav Batra; Guruprasad Medigeshi; Andrew B Ward; Shinjini Bhatnagar; Amit Awasthi; Devin Sok; Jayanta Bhattacharya
Journal:  PLoS Pathog       Date:  2022-04-28       Impact factor: 7.464

4.  SARS-CoV-2 vaccines: anamnestic response in previously infected recipients.

Authors:  Jyothi N Purushotham; Neeltje van Doremalen; Vincent J Munster
Journal:  Cell Res       Date:  2021-08       Impact factor: 46.297

Review 5.  Mounting evidence for immunizing previously infected subjects with a single dose of SARS-CoV-2 vaccine.

Authors:  Gonzalo Perez Marc; Damian Alvarez-Paggi; Fernando P Polack
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 19.456

Review 6.  SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise.

Authors:  Ralf Duerr; Keaton M Crosse; Ana M Valero-Jimenez; Meike Dittmann
Journal:  Microorganisms       Date:  2021-06-27

7.  SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity.

Authors:  Simone I Richardson; Nelia P Manamela; Boitumelo M Motsoeneng; Haajira Kaldine; Frances Ayres; Zanele Makhado; Mathilda Mennen; Sango Skelem; Noleen Williams; Nancy J Sullivan; John Misasi; Glenda G Gray; Linda-Gail Bekker; Veronica Ueckermann; Theresa M Rossouw; Michael T Boswell; Ntobeko A B Ntusi; Wendy A Burgers; Penny L Moore
Journal:  Cell Rep Med       Date:  2022-01-17

8.  Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants.

Authors:  Amarendra Pegu; Sarah O'Connell; Stephen D Schmidt; Sijy O'Dell; Chloe A Talana; Lilin Lai; Jim Albert; Evan Anderson; Hamilton Bennett; Kizzmekia S Corbett; Britta Flach; Lisa Jackson; Brett Leav; Julie E Ledgerwood; Catherine J Luke; Mat Makowski; Paul C Roberts; Mario Roederer; Paulina A Rebolledo; Christina A Rostad; Nadine G Rouphael; Wei Shi; Lingshu Wang; Alicia T Widge; Eun Sung Yang; John H Beigel; Barney S Graham; John R Mascola; Mehul S Suthar; Adrian McDermott; Nicole A Doria-Rose
Journal:  bioRxiv       Date:  2021-05-16

Review 9.  The success of SARS-CoV-2 vaccines and challenges ahead.

Authors:  Kanta Subbarao
Journal:  Cell Host Microbe       Date:  2021-07-14       Impact factor: 21.023

Review 10.  COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era.

Authors:  Ender Volkan
Journal:  Mol Biotechnol       Date:  2021-06-18       Impact factor: 2.695
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.